G. Trofimovičs

发表

Pathological Features of BRCA1/BRCA2 Mutation-Associated Breast Cancer: Implications for Diagnostics and Treatment

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2011 .

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review

J. Gardovskis, A. Irmejs, S. Subatniece, 2021, Hereditary cancer in clinical practice.

Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia

J. Gardovskis, Andris Gardovskis, G. Trofimovics, 2011, BMC Medical Genetics.

Epidemiological, Clinical, Molecular Features and Early Detection Strategy of Most Frequent Hereditary Cancers in Latvia

L. Tihomirova, A. Puķītis, Andrejs Vanags, 2009 .

Breast – conserving Surgery in Early – Stage Triple – Negative Breast Cancer: Is There a Higher Risk of Locoregional Recurrence?

A. Irmejs, J. Maksimenko, E. Miklaševičs, 2012 .

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

J. Gardovskis, G. Purkalne, A. Irmejs, 2018, Hereditary Cancer in Clinical Practice.

Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer

J. Gardovskis, I. Melbărde-Gorkusa, JELENA MAKSIMENKO, 2013, Oncology letters.

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

F. Cardoso, M. Cardoso, J. Gardovskis, 2022, JMIR formative research.

MicroRNA Expression in Different Sybtypes of Breast Cancer

J. Gardovskis, Ilze Strumfa, A. Āboliņš, 2013 .

The Concept, Diagnostics, Surgical Prevention and Treatment of Hereditary Colorectal Cancer in Nowadays Medicine

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2010 .

Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in Latvia.

J. Gardovskis, A. Irmejs, E. Vjaters, 2011, Medicina.

Molecular subtype shift in breast cancer upon trastuzumab treatment: a case report.

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2011, Polish journal of pathology : official journal of the Polish Society of Pathologists.

Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families.

J. Gardovskis, A. Irmejs, V. Borošenko, 2012, Experimental oncology.

Initial results of colorectal polyposis research in Latvia.

Andrejs Vanags, J. Gardovskis, Andris Gardovskis, 2009, Anticancer Research.

Granular Cell Tumour of the Breast Cancer: Challenging Clinical and Radiological Mimic of Cancer

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2012 .

Body mass index and nipple preservation are major contributors to satisfaction and aesthetic outcome rates after implant-based immediate breast reconstruction

J. Gardovskis, A. Irmejs, J. Maksimenko, 2019, Contemporary oncology.

Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.

M. Kals, A. Metspalu, N. Tõnisson, 2022, European journal of medical genetics.

Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients

I. Liepniece-Karele, J. Gardovskis, Andris Gardovskis, 2013, Familial Cancer.

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population

L. Gailīte, J. Gardovskis, A. Irmejs, 2019, Hereditary cancer in clinical practice.

CDH1 Mutation in Two Patients with Hereditary Gastric Cancer

D. Bērziņa, Jelena Pogodina, R. Ribenieks, 2014 .

Hereditary Gastric Cancer: Review of Literature

G. Trofimovics, E. Miklasevics, Jelena Pogodina, 2013 .

Population screening for hereditary and familial cancer syndromes in Valka district of Latvia

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2010, Hereditary cancer in clinical practice.

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers

J. Gardovskis, G. Trofimovics, G. Purkalne, 2021, Hereditary cancer in clinical practice.

Role of Percutaneous Needle Biopsy of Axillary Lymph Nodes to Evaluate Node Positive Breast Cancer after Neoadjuvant Chemotherapy

J. Gardovskis, G. Purkalne, A. Irmejs, 2019, Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences..

The Upgrade of Hereditary Cancer Surveillance Schedule by Valka District Population Screening Data

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2010 .

The first evidence of hereditary and familial gastric cancer in Latvia: implications for prevention.

Andrejs Vanags, J. Gardovskis, Ilze Strumfa, 2012, Medicina.

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population

L. Gailīte, J. Gardovskis, A. Irmejs, 2019, Hereditary Cancer in Clinical Practice.

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

J. Gardovskis, G. Purkalne, A. Irmejs, 2018, Hereditary cancer in clinical practice.

Management of BRCA1 Mutation Carrier with Breast Cancer

J. Gardovskis, Ilze Strumfa, A. Āboliņš, 2011 .